Interaksi Butalbital, aspirin, kafein, dan kodein dan Efavirenz, lamivudin, dan tenofovir

Butalbital, aspirin, kafein, dan kodein dan Efavirenz, lamivudin, dan tenofovir: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Butalbital, aspirin, kafein, dan kodein (BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE) · berlaku sejak 2026-01-15

Mayor

The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with codeine are complex.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Use of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE requires careful consideration of the effects on codeine, and the active metabolite, morphine.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Interactions with Drugs Affecting Cytochrome P450 Isoenzymes The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with codeine are complex.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Moderat

Risks of Interactions with Drugs Affecting Cytochrome P450 Isoenzymes The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with codeine are complex.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Cytochrome P450 3A4 Interaction The concomitant use of BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE with all cytochrome P450 3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir) or discontinuation of a cytochrome P450 3A4 inducer such as rifampin, carbamazepine,…

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Dari label Efavirenz, lamivudin, dan tenofovir (SYMFI) · berlaku sejak 2019-10-15

Mayor

Avoid SYMFI with concurrent or recent use of a nephrotoxic agent (e.g., high-dose or multiple non-steroidal anti-inflammatory drugs [NSAIDs]) [see Drug Interactions (7.3) ] .

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Cases of acute renal failure after initiation of high-dose or multiple NSAIDs have been reported in HIV-infected patients with risk factors for renal dysfunction who appeared stable on TDF.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Alternatives to NSAIDs should be considered, if needed, in patients at risk for renal dysfunction.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Some examples include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.4) ] .

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Narcotic analgesic: Methadone ↓ methadone Monitor for signs of methadone withdrawal and increase methadone dose if required to alleviate withdrawal symptoms.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.